Hi Wanderdog,
I think this is the third time you speak of „mid trial readouts by November“ as this should be „standard clinical practice“.
Sorry for sounding so totally clueless, but what exactly do you mean by this?
And what kind of communication around such mid trial readouts should one expect? A press release saying „everything‘s fine. We proceed with the trial“? Or rather „BCVA so far is x for sham and y for sozinibercept“?
What irritates me further is that after so many years (enrollment started Mar 2021) you are the very first person bringing up the topic of mid trial read outs. I have not seen any analyst nor the company ever bringing up this point.
And further, I do not remember Roche or Novartis having done such mid trial readouts for Vabysmo or Beovu.
If I missed this topic for pure negligence, I beg your pardon. But your expectation of such mid trial readouts, for the moment, really irritates me. As I can‘t make up the context…
So thx a lot for some more meat on the bone from your side.
- Forums
- ASX - By Stock
- Hang in there!!
Hi Wanderdog,I think this is the third time you speak of „mid...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.0¢ |
Change
0.005(0.90%) |
Mkt cap ! $689.4M |
Open | High | Low | Value | Volume |
55.0¢ | 56.5¢ | 55.0¢ | $1.173M | 2.097M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30360 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 35361 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.555 |
3 | 214818 | 0.550 |
2 | 5579 | 0.545 |
2 | 18935 | 0.540 |
2 | 5886 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 20001 | 1 |
0.575 | 38608 | 2 |
0.580 | 24500 | 2 |
0.590 | 19000 | 2 |
0.595 | 1250 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online